{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:55:19Z","timestamp":1786985719297,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012367","name":"MedStar Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.carrev.2024.05.001","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T21:51:26Z","timestamp":1715032286000},"page":"45-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Coronary microvascular dysfunction and cancer therapy-related cardiovascular toxicity"],"prefix":"10.1016","volume":"68","author":[{"given":"Kalyan R.","family":"Chitturi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhdeep","family":"Bhogal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ebrahim","family":"Kassaian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Merdler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waiel","family":"Abusnina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsik","family":"Ben-Dor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Barac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder D.","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2024.05.001_bb0005","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/jnci\/djac158","article-title":"Estimation of the number of individuals living with metastatic Cancer in the United States","volume":"114","author":"Gallicchio","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.carrev.2024.05.001_bb0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41569-020-0347-2","article-title":"Vascular toxic effects of cancer therapies","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0015","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0020","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCRESAHA.121.319901","article-title":"Sex-specific cardiovascular risks of Cancer and its therapies","volume":"130","author":"Wilcox","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.carrev.2024.05.001_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcmg.2022.06.015","article-title":"Ischemia with nonobstructive coronary arteries","volume":"16","author":"Reynolds","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2024.05.001_bb0030","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jacc.2023.06.043","article-title":"Comprehensive management of ANOCA, part 1-definition, patient population, and diagnosis: JACC state-of-the-art review","volume":"82","author":"Samuels","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.amjcard.2023.07.159","article-title":"Understanding patient characteristics and coronary microvasculature: early insights from the coronary microvascular disease registry","volume":"205","author":"Case","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.carrev.2023.03.017","article-title":"The influence of microcirculatory dysfunction on the resting full cycle ratio compared to fractional flow reserve","volume":"54","author":"Troan","year":"2023","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2024.05.001_bb0045","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review","volume":"72","author":"Taqueti","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0050","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cvr\/cvaa009","article-title":"The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions","volume":"116","author":"Konst","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.carrev.2024.05.001_bb0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcmg.2023.07.014","article-title":"Body composition, coronary microvascular dysfunction, and future risk of cardiovascular events including heart failure","volume":"17","author":"Souza","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2024.05.001_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.119.043916","article-title":"Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in patients with chronic kidney impairment","volume":"141","author":"Bajaj","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.05.001_bb0065","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jcmg.2021.11.022","article-title":"Prevalence and prognostic significance of microvascular dysfunction in heart failure with preserved ejection fraction","volume":"15","author":"Arnold","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2024.05.001_bb0070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIRCRESAHA.121.319892","article-title":"Coronary arterial function and disease in women with no obstructive coronary arteries","volume":"130","author":"Reynolds","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.carrev.2024.05.001_bb0075","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the Spectrum of cardiovascular diseases: JACC state-of-the-art review","volume":"78","author":"Del Buono","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0080","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehab775","article-title":"Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis","volume":"43","author":"Kelshiker","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2024.05.001_bb0085","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4244\/EIJ-D-20-00853","article-title":"Prognostic impact and clinical outcomes of coronary flow reserve and hyperaemic microvascular resistance","volume":"17","author":"Toya","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.05.001_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014954","article-title":"Association of isolated coronary microvascular dysfunction with mortality and major adverse cardiac events: a systematic review and meta-analysis of aggregate data","volume":"9","author":"Gdowski","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2024.05.001_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.025171","article-title":"Clinical relevance of ischemia with nonobstructive coronary arteries according to coronary microvascular dysfunction","volume":"11","author":"Lee","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2024.05.001_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcin.2019.11.001","article-title":"1-year outcomes of angina management guided by invasive coronary function testing (CorMicA)","volume":"13","author":"Ford","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.001_bb0105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41569-022-00698-6","article-title":"Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer","volume":"19","author":"Karlstaedt","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0110","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1007\/s12350-021-02825-1","article-title":"Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer","volume":"29","author":"Divakaran","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/eurjpc\/zwac184","article-title":"Coronary microvascular dysfunction is an independent predictor of developing cancer in patients with non-obstructive coronary artery disease","volume":"30","author":"Rajai","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ejhf.2368","volume":"24","author":"Omerovic","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.carrev.2024.05.001_bb0125","first-page":"7","article-title":"Takotsubo cardiomyopathy in cancer patients","volume":"5","author":"Desai","year":"2019","journal-title":"Cardiooncology"},{"key":"10.1016\/j.carrev.2024.05.001_bb0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2023.02.007","article-title":"Cancer and myocardial infarction in women","volume":"194","author":"Panday","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejim.2020.06.018","article-title":"Malignancy in patients with myocardial infarction and non-obstructive coronary arteries: a systematic review and meta-regression","volume":"81","author":"Pelliccia","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.carrev.2024.05.001_bb0140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamacardio.2022.4770","article-title":"Management challenges in patients younger than 65 years with severe aortic valve disease: a review","volume":"8","author":"Baman","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaccao.2022.12.007","article-title":"Screening for coronary artery disease in Cancer survivors: JACC: CardioOncology state-of-the-art review","volume":"5","author":"Velusamy","year":"2023","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0150","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1007\/s12350-020-02255-5","article-title":"Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation","volume":"28","author":"Groarke","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0155","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00370.2019","article-title":"Detrimental effects of chemotherapy on human coronary microvascular function","volume":"317","author":"Hader","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.carrev.2024.05.001_bb0160","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/cvr\/cvab053","article-title":"Coronary microcirculation damage in anthracycline cardiotoxicity","volume":"118","author":"Galan-Arriola","year":"2022","journal-title":"Cardiovasc Res"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924004597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924004597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T15:42:19Z","timestamp":1732030939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838924004597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":32,"alternative-id":["S1553838924004597"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2024.05.001","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary microvascular dysfunction and cancer therapy-related cardiovascular toxicity","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2024.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}